SailPoint Parent LP, the indirect parent company of identity-security solutions provider SailPoint Technologies, on Friday filed for a $100M initial public offering. SailPoint didn’t disclose terms in the filing with the U.

JPMorgan Chase & Co. cut its holdings in shares of Capital Group Core Plus Income ETF (NYSEARCA:CGCP – Free Report) by 7.1% during the 3rd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission.

Ritholtz Wealth Management boosted its position in Annaly Capital Management, Inc. (NYSE:NLY – Free Report) by 36.8% in the 4th quarter, according to its most recent filing with the Securities and Exchange Commission.

Nasdaq chair and CEO Adena Friedman is still a believer in DEI initiatives, and in the IPO market coming back.

Trump administration sparks optimism in South Koreas cryptocurrency market Renewed enthusiasm for cryptocurrencies emerges as South Korea anticipates new regulatory frameworks under Trump.

Donald Trump started his second term as President on Jan. 20, 2025, following his amazing political comeback with a victory in the November election. The new administration is set to bring a wave of significant policy changes.

Experts gather at Koreas virtual asset conference to discuss investment strategies Investment experts convene in Korea to explore virtual asset strategies and market dynamics

Metsera's lead asset is MET-097i, billed as an ultra-long-acting GLP-1 receptor agonist with a profile that could challenge Novo Nordisk's Wegovy (semaglutide) and Eli Lilly's Zepbound (tirzepatide), currently the two biggest-selling obesity drugs.

House Oversight and Accountability Committee Chair James Comer (R-Ky.) said Friday he is investigating the alleged “debanking” of cryptocurrency firms, reaching out to venture capitalist Marc

After years of lobbying by the crypto industry, the U.S. Securities and Exchange Commission has rescinded an accounting rule that forced banks to treat bitcoin and other tokens as a liability on their balance sheets.

Obesity drug developer Aardvark Therapeutics (AARD) has filed for a $100M initial public offering. Aardvark (AARD) didn't disclose any terms in its SEC filing, but indicated in its filing fee schedule that it was looking to raise around $100M, a number that is likely a placeholder and subject to change.

The U.S. Securities and Exchange Commission (SEC) rescinded on Thursday accounting guidance long opposed by the cryptocurrency industry, an early move in President Donald Trump's pivot away from the policies of the prior administration and a win for the crypto sector.